Synchron is a clinical-stage neurotechnology company developing an endovascular brain-computer interface (BCI) designed to restore functionality in people with severe paralysis. Synchron has developed the Stentrode to restore motor signaling to control digital devices and autonomy for individuals with motor impairment. The Stentrode is differentiated by its minimally invasive, endovascular approach that does not require open brain surgery.